Paper36908705
Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis.
Tang W and 6 others. J Oncol, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis. Papers, record 36908705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36908705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28536806 | Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival. | J Gastrointest Surg | 2017 | https://conductscience.org/library/papers/28536806 | PubMed |
| 2 | 33643296 | Advances in Modeling the Immune Microenvironment of Colorectal Cancer. | Front Immunol | 2020 | https://conductscience.org/library/papers/33643296 | PubMed |
| 3 | 31275318 | Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity. | Front Immunol | 2019 | https://conductscience.org/library/papers/31275318 | PubMed |
| 4 | 34697289 | Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy. | Oncogenesis | 2021 | https://conductscience.org/library/papers/34697289 | PubMed |
| 5 | 35914680 | Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis. | Pharmacol Res | 2022 | https://conductscience.org/library/papers/35914680 | PubMed |
| 6 | 6722186 | Rapid purification and activity of apolipoprotein C1 on the proliferation of bovine vascular endothelial cells in vitro. | Biochim Biophys Acta | 1984 | https://conductscience.org/library/papers/6722186 | PubMed |
| 7 | 19236898 | Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. | Hum Immunol | 2009 | https://conductscience.org/library/papers/19236898 | PubMed |
| 8 | 31455888 | Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/31455888 | PubMed |
| 9 | 24741617 | Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis. | J Immunol Res | 2014 | https://conductscience.org/library/papers/24741617 | PubMed |
| 10 | 33591959 | Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance. | Med Sci Monit | 2021 | https://conductscience.org/library/papers/33591959 | PubMed |
| 11 | 26964802 | Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality. | Clin Colorectal Cancer | 2016 | https://conductscience.org/library/papers/26964802 | PubMed |
| 12 | 29737570 | MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/29737570 | PubMed |
| 13 | 21689362 | Ablative therapies for colorectal liver metastases: a systematic review. | Colorectal Dis | 2011 | https://conductscience.org/library/papers/21689362 | PubMed |
| 14 | 31213910 | Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31213910 | PubMed |
| 15 | 26028255 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26028255 | PubMed |
| 16 | 35741652 | The Progression Related Gene RAB42 Affects the Prognosis of Glioblastoma Patients. | Brain Sci | 2022 | https://conductscience.org/library/papers/35741652 | PubMed |
| 17 | 35414780 | MGP promotes CD8+ T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/35414780 | PubMed |
| 18 | 35720121 | RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35720121 | PubMed |
| 19 | 23423980 | The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked? | Cancer Res | 2013 | https://conductscience.org/library/papers/23423980 | PubMed |
| 20 | 28732212 | UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. | Neoplasia | 2017 | https://conductscience.org/library/papers/28732212 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942113 | Tumor-Centric Immune Crosstalk in Colorectal and Gastric Cancer: Molecular Mechanisms Linking Tumor Cells to Macrophages and CD8+ T Lymphocytes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942113 | PubMed |
| 42348034 | Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42348034 | PubMed |
| 41894110 | Analysis and validation of mast cells and enriched genes in colorectal cancer with liver metastasis by multi-omics data. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41894110 | PubMed |
| 41071085 | Potential of Serum ApoC1 as a Noninvasive Biomarker for Breast Cancer Detection and Prognosis: A Prospective Case-Control Study. | Cancer Rep (Hoboken) | 2025 | https://conductscience.org/library/papers/41071085 | PubMed |
| 41053280 | Transcriptome analysis combined with single-cell analysis identified that APOC1 influences cholesterol transport by macrophages in ccRCC. | Sci Rep | 2025 | https://conductscience.org/library/papers/41053280 | PubMed |
| 40349270 | The roles, signalling pathways and therapeutic implications of Apoc1 in cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40349270 | PubMed |
| 39665592 | Candidate Genetic Loci Modifying the Colorectal Cancer Risk Caused by Lifestyle Risk Factors. | Clin Transl Gastroenterol | 2025 | https://conductscience.org/library/papers/39665592 | PubMed |
| 39511608 | HOXD9/APOC1 axis promotes macrophage M1 polarization to exacerbate diabetic kidney disease progression through activating NF-κB signaling pathway. | Hereditas | 2024 | https://conductscience.org/library/papers/39511608 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36908705
GET https://conductscience.org/api/papers/v1/36908705/references?page=2